|
|||||
|
|
| 中医/中西医结合临床路径研发的关键问题分析 | |
| 引用本文： | 吴大嵘,周罗晶,王思成,唐雪春,刘建平,吕玉波. 中医/中西医结合临床路径研发的关键问题分析[J]. 中国中西医结合杂志, 2010, 30(11): 1206-1208 |
| 作者姓名： | 吴大嵘 周罗晶 王思成 唐雪春 刘建平 吕玉波 |
| 作者单位： | 1. 广州中医药大学第二临床医学院,广州,510120;广东省中医药科学院 2. 苏北人民医院 3. 国家中医药管理局科技司 4. 北京中医药大学循证医学中心 |
| 基金项目： | 国家中医药管理局公益性行业科研专项--基于糖尿病周围神经病变等7个单病种中医最佳诊疗方案的临床路径共性技术研究，广东省财政厅项目"中医药疗效评价体系理论模型的论证与研究" |
| 摘 要： | 与西医学相比，中医/中西医结合临床路径的研发一方面需要遵循路径制定的基本原则，另一 |
| 关 键 词： | 中医/中西医结合；临床路径；研发 |
Key Issues on the Clinical Pathway Development:A View from Chinese Medicine and Integrative Medicine |
|
| WU Da-rong,ZHOU Luo-jing,WANG Si-cheng. Key Issues on the Clinical Pathway Development:A View from Chinese Medicine and Integrative Medicine[J]. Chinese journal of integrated traditional and Western medicine, 2010, 30(11): 1206-1208 | |
| Authors: | WU Da-rong ZHOU Luo-jing WANG Si-cheng |
| Affiliation: | WU Da-rong, ZHOU Luo-jing, WANG Si-cheng, et al The Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou (510120) |
| Abstract: | Comparing with the Western medicine,the clinical pathway development of Chinese medicine（CM） /integrative medicine（IM）,on one hand,should follow the basic principles of general clinical pathway;on the other and prior hand,it ought to coordinate with the rule of CM,and display sufficiently the advantages of CM based upon the evidences.Several key issues which may be encountered in the development and the relevant strategies were introduced in this paper. |
| Keywords: | Chinese medicine/integrative medicine clinical pathway development |
| 本文献已被 维普 万方数据 等数据库收录！ | |
| 点击此处可从《中国中西医结合杂志》浏览原始摘要信息 | |
| 点击此处可从《中国中西医结合杂志》下载全文 | |